NASDAQ:SRRK

Scholar Rock Holding Stock Insider Trading

Healthcare > Biotechnology

Buy SRRK

*Your capital is at risk

$44.64

-0.0400 (-0.0895%)

At Close: Jun 03, 2026

Scholar Rock Holding Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 14.37. In total, the insiders bought 4.55M and sold 3.55M SRRK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	14.37
● Buy	4.55M shares
● Sell	3.55M shares
57% Buy Activity Weak Negative Correlation
Sell Signal Low Confidence Apr 16, 2026 Analysis Breakdown: Weakened by a contradictory positive Insider Power Score. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 23, 2026 Buy	Common Stock M-Exempt	Burow Kristina Director	Director	7 800 Value: $208.9K
Apr 23, 2026 Buy	Common Stock M-Exempt	Burow Kristina Director	Director	28 000 Value: $133.0K
Apr 23, 2026 Buy	Common Stock M-Exempt	Burow Kristina Director	Director	36 000 Value: $328.0K
Apr 23, 2026 Buy	Common Stock M-Exempt	Burow Kristina Director	Director	18 000 Value: $150.5K
Apr 23, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Burow Kristina Director	Director	18 000 Value: $150.5K
Apr 23, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Burow Kristina Director	Director	7 800 Value: $208.9K
Apr 23, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Burow Kristina Director	Director	28 000 Value: $133.0K
Apr 23, 2026 Buy	Stock Option (Right to Buy) M-Exempt	Burow Kristina Director	Director	36 000 Value: $328.0K
Apr 16, 2026 Sell	Common Stock S-Sale	Hallal David Chief Executive Officer	CEO / President	30 615 Value: $1.52M
Apr 16, 2026 Sell	Common Stock S-Sale	Woods Keith Chief Operating Officer	C-Suite Officer	10 220 Value: $506.7K
Apr 16, 2026 Sell	Common Stock S-Sale	Vaishnaw Akshay President Of R&d	CEO / President	12 246 Value: $607.1K
Apr 16, 2026 Sell	Common Stock S-Sale	Sinha Vikas Chief Financial Officer	C-Suite Officer	10 410 Value: $516.1K
Feb 23, 2026 Sell	Common Stock S-Sale	Qatanani Mo Chief Scientific Officer	Officer	7 427 Value: $348.6K
Feb 23, 2026 Sell	Common Stock S-Sale	Qatanani Mo Chief Scientific Officer	Officer	857 Value: $41.0K
Feb 23, 2026 Sell	Common Stock S-Sale	Qatanani Mo Chief Scientific Officer	Officer	200 Value: $10K
Feb 17, 2026 Sell	Common Stock S-Sale	Qatanani Mo Chief Scientific Officer	Officer	7 989 Value: $371.7K
Feb 17, 2026 Sell	Common Stock S-Sale	Parlavecchio Caryn Chro	Officer	9 035 Value: $420.4K
Feb 17, 2026 Sell	Common Stock S-Sale	Ho Junlin General Counsel	Officer	9 580 Value: $445.7K
Feb 17, 2026 Sell	Common Stock S-Sale	Marantz Jing L. Chief Medical Officer	Officer	4 157 Value: $193.4K
Feb 09, 2026 Buy	Common Stock A-Award	Ho Junlin General Counsel	Officer	36 572 Value: $1.75M
Feb 09, 2026 Buy	Common Stock A-Award	Marantz Jing L. Chief Medical Officer	Officer	34 482 Value: $1.65M
Feb 09, 2026 Buy	Common Stock A-Award	Vaishnaw Akshay President Of R&d	CEO / President	47 021 Value: $2.25M
Feb 09, 2026 Buy	Common Stock A-Award	Sinha Vikas Chief Financial Officer	C-Suite Officer	47 021 Value: $2.25M
Feb 09, 2026 Buy	Common Stock A-Award	Qatanani Mo Chief Scientific Officer	Officer	29 258 Value: $1.40M
Feb 09, 2026 Buy	Common Stock A-Award	Parlavecchio Caryn Chief Human Resources Officer	Officer	29 258 Value: $1.40M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT SCHOLAR ROCK HOLDING CORP.

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical tria...

Read Full Profile Here